about
Radiofrequency ablation without the use of fluoroscopy - in what kind of patients is it feasible?Association between variants on chromosome 4q25, 16q22 and 1q21 and atrial fibrillation in the Polish populationThe 4q25, 1q21, and 16q22 polymorphisms and recurrence of atrial fibrillation after pulmonary vein isolation.Study design and rationale for biomedical shirt-based electrocardiography monitoring in relevant clinical situations: ECG-shirt study.Antiarrhythmic therapy as an adjuvant to promote post pulmonary vein isolation success-a meta-analysis.Does a blanking period after pulmonary vein isolation impact long-term results? Results after 55 months of follow-up.Initial experience of catheter ablation for cardiac arrhythmias in children and adolescents at a newly built ablation centre.Influence of left atrial size on the outcome of pulmonary vein isolation in patients with atrial fibrillation.Comparison of clinical characteristics of real-life atrial fibrillation patients treated with vitamin K antagonists, dabigatran and rivaroxaban: results from the CRAFT study.Dual antiplatelet therapy is safe and efficient after left atrial appendage closure.First-in-man percutaneous pulmonary vein isolation enhanced by augmented reality system.The influence of the atrial fibrillation episode duration on the endothelial function in patients treated with pulmonary veins isolation.Antazoline for termination of atrial fibrillation during the procedure of pulmonary veins isolation.Efficacy of multi-electrode duty-cycled radiofrequency ablation in patients with paroxysmal and persistent atrial fibrillation.Three-dimensional print facilitated ventricular tachycardia ablation in patient with corrected congenital heart diseaseLack of movement of the cardiac silhouette in fluoroscopy is an early sign of pericardial fluid during catheter ablation: a three-case report
P50
Q33411725-7DC4A1AF-1BFD-43DB-BEBE-CFE7444ABC8BQ33961522-40D81F8E-9FB2-4224-B88B-30390BEC4684Q36582320-C120E548-DF5A-436F-92F9-F5AABC7464E7Q38371680-85D31F68-6468-488C-B1F6-2FCE98C16488Q38880992-8C6D1210-2CD5-4A60-913B-F74F4B4745BFQ45897234-021AB3AA-2513-423A-82C2-CE9CF81A4003Q47290371-4C801447-866B-4B61-B047-4549AE18E1AEQ47417569-CCD9C495-B99C-458A-ADE5-FAB20796A80BQ47551351-CE7B5210-B04C-494C-96ED-556E9A53C2A1Q48531247-EC8D0582-E8C4-42DE-8A37-47555CBBD394Q49852594-BEC20C21-63B4-42E9-AD6C-0C9A868C7E2AQ50736344-23DDD534-0FBB-44D1-AEF2-795101C45423Q51029642-67853E4F-7635-4A9D-8245-22711BDA9154Q54439753-FF526668-D2B1-4899-886E-5015951B709EQ58841117-E294569E-9261-426E-AD3E-92AE6B8AA4C7Q86984967-D4E77AD3-D4C7-4669-9A2D-DCA2097E6B0B
P50
description
researcher ORCID ID = 0000-0002-1747-5999
@en
name
Piotr Lodziński
@ast
Piotr Lodziński
@ca
Piotr Lodziński
@cs
Piotr Lodziński
@en
Piotr Lodziński
@es
Piotr Lodziński
@gl
Piotr Lodziński
@hr
Piotr Lodziński
@hsb
Piotr Lodziński
@it
Piotr Lodziński
@nl
type
label
Piotr Lodziński
@ast
Piotr Lodziński
@ca
Piotr Lodziński
@cs
Piotr Lodziński
@en
Piotr Lodziński
@es
Piotr Lodziński
@gl
Piotr Lodziński
@hr
Piotr Lodziński
@hsb
Piotr Lodziński
@it
Piotr Lodziński
@nl
prefLabel
Piotr Lodziński
@ast
Piotr Lodziński
@ca
Piotr Lodziński
@cs
Piotr Lodziński
@en
Piotr Lodziński
@es
Piotr Lodziński
@gl
Piotr Lodziński
@hr
Piotr Lodziński
@hsb
Piotr Lodziński
@it
Piotr Lodziński
@nl
P1153
8677187700
P1412
P1559
Piotr Lodziński
@pl
P21
P214
66152682585323312600
P27
P31
P3124
P496
0000-0002-1747-5999
P735
P7859
viaf-66152682585323312600